Viracta Therapeutics Inc (VIRX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Viracta Therapeutics Inc   (NASDAQ: VIRX)

Viracta Therapeutics Inc

Officers & Directors


Ivor Royston, M.D.
Director

Thomas Darcy
Director

Daniel Chevallard
Chief Operating Officer and Chief Financial Officer

Flavia Borellini, Ph.D.
Director

Jane Chung, R. Ph.
Director

Jane Barlow, M.D., MPH, MBA
Director

Sam Murphy, Ph.D.
Director

Barry Simon, M.D.
Director

Daniel Chevallard
Chief Operating Officer, Chief Financial Officer and Secretary (Principal Financial and Accounting Officer)

Mark Rothera
President and Chief Executive Officer (Principal Executive Officer)

Roger Pomerantz, M.D.
Chairman of the Board of Directors

Mark Rothera
President and Chief Executive Officer

Stephen Rubino, Ph.D., MBA
Director ,

Viracta Therapeutics Inc currently has 12 employees.






VIRX Management Effectiveness VIRX Revenue per Employee VIRX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.